Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
about
The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceHeterogeneity of mammary lesions represent molecular differencesAdenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.What have we learned about GPER function in physiology and disease from knockout mice?Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopauseUse of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCISOspemifene use in postmenopausal women.Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonistNew insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.Pharmacologic evaluation of ospemifene.Critical choices for modeling breast cancer in transgenic mouse models.Profile of ospemifene in the breast.Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study.Precancer in mice: animal models used to understand, prevent, and treat human precancers.Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression.
P2860
Q26830744-D4D31FCD-728E-458A-8309-255C6E52019FQ33265521-8853888D-F181-407C-8F3A-9DCEB444A623Q33690360-FD0A2726-58DF-4C9D-A962-FE2D8AD966C8Q34001014-C27D8C9B-3F5D-466B-BB97-EEAD852F346FQ34369252-3A3E89C8-C06B-447A-BAAA-6B342E13C949Q34485765-9F7B224E-3F90-418E-862E-C9406BFF02C2Q34532021-4733A2B4-3E67-414E-80B6-06256BA0C0E2Q34550833-27ACE545-8D0F-4D30-87DB-456C3F7FA42CQ34982860-AF82613A-D01C-4413-8832-0510CE9379FEQ35000523-44F2A68A-258E-486C-AE45-DBAE0CD79B97Q35234634-11952930-EF76-4B57-A8F7-67D17BF6B366Q35634204-8DA72B8F-AC7C-44EE-AC38-0B93E5660231Q36338306-E18ACF1F-A9F1-4D77-9FBB-C859E9F193D7Q36927087-032A2C72-6D9B-4F6A-A54A-23DBAF534050Q37156496-181975CD-FAB4-46D2-8D43-B08BE45A00A8Q37221035-E20E1EFC-077B-4D27-83E2-0365631F7C0AQ37739433-1AE6AD9D-05C7-4CA4-9BC2-797191B0EA22Q37968500-50B47C50-54AF-4C28-9072-65C07387A257Q38129004-88725FEC-6059-4987-A7AD-73F20E2132EDQ41110474-0666826A-E928-4D31-8F52-AC47C3CC8692Q44849422-92908E3D-82E9-4499-90D1-577868FC4265Q46530065-20FB20C7-DBBA-46C0-A9B0-AEADBA883B9FQ52322881-76AAE9E7-E498-468C-9642-3065214D461B
P2860
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Selective estrogen receptor mo ...... el of ductal carcinoma in situ
@nl
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@ast
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@en
type
label
Selective estrogen receptor mo ...... el of ductal carcinoma in situ
@nl
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@ast
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@en
prefLabel
Selective estrogen receptor mo ...... el of ductal carcinoma in situ
@nl
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@ast
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@en
P2093
P2860
P356
P1476
Selective estrogen receptor mo ...... l of ductal carcinoma in situ.
@en
P2093
Alexander D Borowsky
Carol L MacLeod
Erik T McGoldrick
Gregory T Wurz
Jeannie E Maglione
Jeffrey P Gregg
Lawrence J T Young
Michael W DeGregorio
Robert D Cardiff
Ruria Namba
P2860
P2888
P304
P356
10.1186/BCR1317
P407
P577
2005-09-13T00:00:00Z
P5875
P6179
1053459737